Working groups
Bryce completed his Bachelor of Science at Monash University in 2020 with an emphasis in microbiology and molecular biology.
Prior to joining the Burnet Diagnostics Initiative (BDI), Bryce worked as a medical scientist in a private pathology lab where his passion for diagnostics began. Bryce was able to develop skills in both PCR (SARS-CoV-2, CT/NG, Respiratory Multiplex) as well as immunoserological testing (syphilis, TB). His desire to understand diseases, particularly in the areas of diagnosis, treatment, and elimination, drives him to further his skills and knowledge in the field.
We’re developing a novel class of antibody and delivery technologies to provide enhanced protection and therapeutic performance for coronaviruses and other respiratory infections.
A rapid point-of-care (POC) test for liver disease biomarkers could improve the management of acute and chronic liver disease and reduce the progression to liver cancer in Australia and globally.
We're developing point-of-care diagnostics for active syphilis, aiming to transform syphilis management globally and contribute to World Health Organization goals.